Indiana University Med Center

Indianapolis, Indiana 46202-5121

0 studies enrolling now · 5 studies all time

What they study most

Cancer, Hepatitis B, Hepatitis C, Neoplasm Metastasis, Tumor, Tumors

Studies at this site

• Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study) — Completed
• UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects — Completed
• Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation — Completed
• A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors — Completed
• MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors — Completed